Neogen Corporation Marketable Securities (Current)
Neogen Corporation (NEOG) had Marketable Securities (Current) of $0 as of 2025-05-31, per its 10-K filed 2025-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-07-30
- 2025-05-31: Marketable Securities, Current $0.00.
- 2025-02-28: Marketable Securities, Current $0.00.
- 2024-11-30: Marketable Securities, Current $0.00.
- 2024-08-31: Marketable Securities, Current $0.00.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-05-31 | $0.00 10-K · filed 2025-07-30 |
| 2025-02-28 | $0.00 10-Q · filed 2025-04-09 |
| 2024-11-30 | $0.00 10-Q · filed 2025-01-15 |
| 2024-08-31 | $0.00 10-Q · filed 2024-10-10 |
| 2024-05-31 | $325.00K 10-K · filed 2025-07-30 |
| 2024-02-29 | $7.01M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $24.50M 10-Q · filed 2024-01-09 |
| 2023-08-31 | $60.42M 10-Q · filed 2023-10-10 |
| 2023-05-31 | $82.33M 10-K · filed 2024-07-30 |
| 2023-02-28 | $116.08M 10-Q · filed 2023-04-04 |
| 2022-11-30 | $176.34M 10-Q · filed 2023-01-09 |
| 2022-08-31 | $240.61M 10-Q · filed 2022-09-30 |
| 2022-05-31 | $336.58M 10-K · filed 2023-08-15 |
| 2022-02-28 | $335.56M 10-Q · filed 2022-04-01 |
| 2021-11-30 | $338.13M 10-Q · filed 2021-12-30 |
| 2021-08-31 | $329.60M 10-Q · filed 2021-09-30 |
| 2021-05-31 | $305.49M 10-K · filed 2022-07-27 |
| 2021-02-28 | $279.87M 10-Q · filed 2021-03-31 |
| 2020-11-30 | $276.90M 10-Q · filed 2020-12-29 |
| 2020-08-31 | $306.54M 10-Q · filed 2020-09-30 |
| 2020-05-31 | $277.40M 10-K · filed 2021-07-30 |
| 2020-02-29 | $277.15M 10-Q · filed 2020-04-03 |
| 2019-11-30 | $247.19M 10-Q · filed 2019-12-27 |
| 2019-08-31 | $234.73M 10-Q · filed 2019-09-26 |
| 2019-05-31 | $225.84M 10-K · filed 2020-07-30 |
| 2019-02-28 | $153.10M 10-Q · filed 2019-03-29 |
| 2018-11-30 | $139.38M 10-Q · filed 2018-12-28 |
| 2018-08-31 | $129.19M 10-Q · filed 2018-10-05 |
| 2018-05-31 | $127.74M 10-K · filed 2019-07-30 |
| 2018-02-28 | $110.09M 10-Q · filed 2018-03-29 |
| 2017-11-30 | $111.41M 10-Q · filed 2018-01-05 |
| 2017-08-31 | $101.53M 10-Q · filed 2017-09-29 |
| 2017-05-31 | $66.07M 10-K · filed 2018-07-27 |
| 2017-02-28 | $64.70M 10-Q · filed 2017-03-31 |
| 2016-11-30 | $55.81M 10-Q · filed 2016-12-29 |
| 2016-08-31 | $53.04M 10-Q · filed 2016-09-30 |
| 2016-05-31 | $52.54M 10-K · filed 2017-07-28 |
| 2016-02-29 | $58.30M 10-Q · filed 2016-03-31 |
| 2015-11-30 | $51.64M 10-Q · filed 2016-01-08 |
| 2015-08-31 | $68.63M 10-Q · filed 2015-09-30 |
| 2015-05-31 | $48.10M 10-K · filed 2016-07-29 |
| 2015-02-28 | $44.66M 10-Q · filed 2015-04-01 |
| 2014-11-30 | $45.25M 10-Q · filed 2014-12-30 |
| 2014-08-31 | $34.64M 10-Q · filed 2014-09-30 |
| 2014-05-31 | $35.82M 10-K · filed 2015-07-30 |
| 2014-02-28 | $25.53M 10-Q · filed 2014-04-04 |
| 2013-11-30 | $35.48M 10-Q · filed 2014-01-09 |
| 2013-08-31 | $40.77M 10-Q · filed 2013-09-30 |
| 2013-05-31 | $35.34M 10-K · filed 2014-07-30 |
| 2013-02-28 | $25.70M 10-Q · filed 2013-03-28 |
| 2012-11-30 | $29.53M 10-Q · filed 2012-12-28 |
| 2012-08-31 | $30.02M 10-Q · filed 2012-09-28 |
| 2012-05-31 | $19.60M 10-K · filed 2013-07-30 |
| 2012-02-29 | $18.64M 10-Q · filed 2012-03-30 |
| 2011-11-30 | $18.63M 10-Q · filed 2011-12-30 |
| 2011-08-31 | $29.32M 10-Q · filed 2011-09-30 |
| 2011-05-31 | $20.24M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |